Correlation Between Dianthus Therapeutics and Evelo Biosciences

Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Evelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Evelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dianthus Therapeutics and Evelo Biosciences, you can compare the effects of market volatilities on Dianthus Therapeutics and Evelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Evelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Evelo Biosciences.

Diversification Opportunities for Dianthus Therapeutics and Evelo Biosciences

0.0

Correlation Coefficient

Dianthus Therapeutics  Evelo Biosciences

Pay attention - limited upside

The 3 months correlation between Dianthus and Evelo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Evelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evelo Biosciences and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Evelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evelo Biosciences has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Evelo Biosciences go up and down completely randomly.

Pair Corralation between Dianthus Therapeutics and Evelo Biosciences

If you would invest (100.00) in Evelo Biosciences on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Evelo Biosciences or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Dianthus Therapeutics  vs.  Evelo Biosciences

Dianthus Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Dianthus Therapeutics is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Evelo Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Evelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Evelo Biosciences is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Dianthus Therapeutics and Evelo Biosciences

The main advantage of trading using opposite Dianthus Therapeutics and Evelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Evelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evelo Biosciences will offset losses from the drop in Evelo Biosciences' long position.

The idea behind Dianthus Therapeutics and Evelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.